You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR CIDOFOVIR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Cidofovir

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000135 ↗	Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 2/Phase 3	1995-09-01	To evaluate the efficacy and safety of a human anti-CMV monoclonal antibody, MSL-109, as adjunct therapy for controlling CMV retinitis.
NCT00000142 ↗	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)	Completed	Baylor College of Medicine	Phase 2/Phase 3	1994-04-01	To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
NCT00000142 ↗	Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)	Completed	Icahn School of Medicine at Mount Sinai	Phase 2/Phase 3	1994-04-01	To test and evaluate the efficacy and safety of intravenous cidofovir (Vistide, previously known as HPMPC) for the treatment of retinitis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Cidofovir

Condition Name

Chart
Table

Condition Name for Cidofovir
Intervention	Trials
HIV Infections	15
Cytomegalovirus Retinitis	10
Cytomegalovirus Infections	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Cidofovir
Intervention	Trials
HIV Infections	16
Retinitis	11
Cytomegalovirus Retinitis	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Cidofovir

Trials by Country

Map
Table

Trials by Country for Cidofovir
Location	Trials
United States	114
France	14
Belgium	8
United Kingdom	7
Australia	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Cidofovir
Location	Trials
California	12
Texas	11
New York	9
North Carolina	8
Illinois	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Cidofovir

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Cidofovir
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	8
Phase 2/Phase 3	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Cidofovir
Clinical Trial Phase	Trials
Completed	27
Unknown status	5
Not yet recruiting	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cidofovir

Sponsor Name

Chart
Table

Sponsor Name for Cidofovir
Sponsor	Trials
Gilead Sciences	10
National Institute of Allergy and Infectious Diseases (NIAID)	6
M.D. Anderson Cancer Center	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Cidofovir
Sponsor	Trials
Other	44
Industry	20
NIH	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.